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Aim: The contribution of lower extremity venous duplex scan to the diagnostic strategy for 
pulmonary embolism has been demonstrated by many authors. However, the positive diagnos-
tic value of this noninvasive test in clinically suspected pulmonary embolism is not very high 
(10%–18%). Since thromboembolic risks increase considerably in hospitalized patients with 
advanced age, this study aims to determine the importance of lower extremity venous color 
flow duplex scan in this particular subgroup of patients with clinically suspected pulmonary 
embolism. The effects of clinical presentation and risk factors on the results of duplex scan 
have been also studied.
Methods: Between July 2007 and January 2010, 95 consecutive Lebanese geriatric ($60 years 
of age) inpatients with clinically suspected pulmonary embolism assessed in an academic tertiary-
care center for complete lower extremity venous color flow duplex scan were retrospectively 
reviewed. Age varied between 60 and 96 years (mean, 79.9 years). Forty patients were males 
and 55 females. Absence of compressibility was the most important criteria for detecting acute 
venous thrombosis.
Results: Out of 95 patients, 33 patients (34.7%) were diagnosed with recent deep venous 
thrombosis of lower extremities (14 proximal and 19 distal) using complete venous ultrasound. 
Nine of these 33 patients (27.2%) had a history of venous thromboembolism and eleven (33.3%) 
presented with edema of lower extremities. A total of 28 patients (84.8%) with positive duplex 
scan had associated risk factors for venous thromboembolism.
Conclusion: Lower extremity venous color flow duplex scan appears to be a reasonable initial 
screening test in the diagnostic algorithm of pulmonary embolism in geriatric inpatients with 
clinically suspected pulmonary embolism. This is particularly true in patients with a history of 
venous thromboembolism, in patients with a clinical presentation suggesting venous thrombosis, 
in uremic patients and in patients with altered general and mental status who are not candidates 
for chest computed tomography.
Keywords: venous thrombosis, lower extremities, geriatric
Introduction
Venous thromboembolism (VTE) is actually the third most common cardiovascular 
disorder following only myocardial infarction and stroke.1 Pulmonary embolism (PE) 
is the most important short-term complication of acute deep vein thrombosis (DVT). 
Mortality after PE is high.2–4 Increased age or confinement to a hospital or nursing 
home are considered independent predictors of reduced early survival after PE.2,3,5 In 
hospitalized patients, PE is one of the most common, yet highly preventable, causes 
of in-hospital death. The nonspecific signs and symptoms of PE in association with 
risk factors are insufficient to allow for a definitive diagnosis and should prompt the 
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physician to further investigation.6 The importance of   correct 
diagnosis and timely treatment is essential to prevent poten-
tial life-threatening consequences of PE.7
Ninety percent of PE originates from lower limb DVT.8,9 
Symptomatic PE accompanies approximately 10% of DVT 
cases.10,11 Many imaging modalities have been used in the 
diagnostic strategy for the detection of PE. Venous ultrasound 
has evolved as the initial screening test for patients with 
clinically suspected PE in some centers.12 DVT detectable by 
lower extremity venous ultrasound in clinically suspected PE 
is not common and varies between 10% and 18%.12–14 Only 
one study reported a relatively high positive venous ultra-
sound rate (30.4%) when the exploration includes the entire 
venous system from the inferior vena cava to the ankles and 
examines not only the deep collectors but also the muscles 
and superficial networks.15
Thromboembolic risks increase in patients with advanced 
age and in hospitalized patients. Advanced age has been most 
consistently associated with an increased risk of VTE as 
demonstrated in the authors’ previous published studies.16,17 
VTE is predominantly a disease of older age.18–20 The inci-
dence of DVT rises nearly 90-fold between 15 and 80 years 
of age with a relative risk of 1.9 for each 10-year increase 
in age.21 For these reasons, geriatric population was selected 
in this study.
Knowing that hospitalization is also considered a major 
independent risk for VTE,22,23 Perrier suggested assessing 
duplex scan performance and refining diagnostic strategies 
in distinct patient subgroups, particularly those hospitalized.24 
In fact, hospitalization and nursing-home residents together 
account for almost 60% of incident VTE events occurring 
in the community.23 Compared with residents in the commu-
nity, hospitalized residents have over a 150-fold increased 
incidence of acute VTE.25
The authors of the paper did not find in the literature any 
publication providing adequate information about the value 
of venous ultrasound in geriatric hospitalized patients with 
clinically suspected PE. The aim of this study is to evaluate 
the importance of color flow lower extremity venous ultra-
sound for the diagnosis of PE in this high risk subgroup of 
patients and to assess the role of clinical presentation and 
risk factors on the results of venous ultrasound.
Materials and methods
From July 2007 to January 2010, 95 consecutive Lebanese 
geriatric ($60 years of age) inpatients with clinically sus-
pected PE assessed in an academic tertiary center for lower 
extremity complete venous color flow ultrasound (ProSound 
Alpha 7, ALOKA, Zug, Switzerland) were retrospectively 
reviewed. Age varied between 60 and 96 years (mean, 
78 years). A total of 83 patients (87.3%) were 70 years and 
above, 41 (43.1%) were 80 years and above, and nine (9.5%) 
were 90 years and above. Forty patients were males and 55 
were females. Clinical symptoms and signs suggesting PE 
were tachypnea, dyspnea, chest pain, tachycardia, syncope, 
sudden hypotension, and hypoxemia.26
All the veins of both lower extremities including calf 
veins and iliac veins were completely studied. Absence of 
compressibility was the most important criteria for detecting 
acute venous thrombosis. Other criteria such as increased 
cross-sectional diameter, increased intraluminal reflection 
intensity, no vascular caliber variation during respiration 
maneuvers, and no Doppler signal were also considered 
helpful in confirming acute venous thrombosis.27 The asso-
ciation of color flow and power flow Doppler to the simple 
ultrasound considerably improved the accuracy of this exam 
in segments which are difficult to evaluate (iliac veins, calf 
veins).28
Moreover, a clinical research form was filled out for every 
patient, by a retrospective evaluation of clinical presentation 
and risk factors for venous thrombosis; data was entered and 
analyzed by SPSS Statistics (IBM Corporation, Somers, NY) 
software, version 13.0. A chi-square test was used to correlate 
between dichotomous variables, and a Fisher exact test was 
used in case of calculated values that were lower than five. 
Clinical presentation and risk factors for venous thrombosis 
were determined in both positive and negative lower extrem-
ity venous ultrasound groups. Presenting symptoms and 
signs were essentially dyspnea for PE, and alteration of the 
general status including fever and lower extremity edema 
for DVT. Risk factors involved in the development of VTE 
included renal failure, history of VTE, obesity, hip fracture 
and surgery, superficial venous insufficiency, immobiliza-
tion, heart failure, recent surgery, cancer, respiratory failure, 
lung infection, sepsis, hemiplegia, acute pancreatitis, cardiac 
catheterization, chronic lung disease (chronic obstructive 
pulmonary disease, emphysema, asthma, pulmonary fibro-
sis), coronary artery disease, quadriplegia, leg fracture and 
intracranial bleeding.
Results
Of the 95 reported patients, 33 (34.7%) were diagnosed with 
recent acute DVT of lower extremities using complete lower 
extremity venous ultrasound. Venous thrombosis was local-
ized on the right side in eight patients, on the left side in 15 
patients, and on both sides in ten patients. Thrombosis was 
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observed at the ilio-femoral level in one patient, at the 
femoro-popliteal level in 13 patients, and at the calf vein 
level in 19 patients.
Among the 33 patients diagnosed with DVT using com-
plete venous ultrasound, 31 (93.9%) suffered from dyspnea, 
which was acute in eight patients (27.2%) and nonacute in 
23 patients (69.6%). Eleven patients (33.3%) presented with 
leg edema, which was unilateral in four patients (12.1%) and 
bilateral in seven patients (21.2%). Five patients (15.1%) had 
alteration of general and mental status. Associated risk fac-
tors for VTE were reported in 28 patients (84.8%).   Seventeen 
patients (51.5%) had one risk factor, seven (21.2%) had two 
risk factors, three (9%) had three risk factors, and one (3%) 
had four risk factors. The most commonly observed risk 
factors were a history of previous VTE (27.2%), obesity 
(24.2%), surgery (21.1%) including hip fracture and hip 
surgery (12.1%), superficial venous insufficiency (9%), 
immobilization (9%), heart failure (9%), respiratory failure 
(6%), and cancer (6%). All these findings are summarized 
and compared with those observed in the second group of 
patients in whom DVT was not detected (Tables 1 and 2). 
Bivariate analysis demonstrated that hip surgery increased the 
risk for VTE (Table 2). The role of obesity in increasing VTE 
risks was not statistically demonstrated (Table 2). The pres-
ence of lower extremity edema was a predictor for positive 
venous ultrasound (Table 1). A history of VTE as a predictor 
for positive ultrasound did not reach statistically significant 
levels (Table 2). On the other side, chronic pulmonary disease 
and coronary artery disease were poorly correlated with the 
presence of VTE and consequently with a positive venous 
ultrasound (Table 2).
Discussion
Suspected PE is usually managed using algorithms combin-
ing clinical probability, ventilation/perfusion scan, com-
puted tomography (CT), and lower extremities ultrasound. 
  Multidetector-row CT (MDCT), recently introduced, has 
been firmly established as the first-line test for imaging 
patients with suspected PE.29–33
There is actually a conclusive evidence that MDCT scan 
if positive provides reliable confirmation of the presence of 
PE and more importantly if negative rules out clinically sig-
nificant PE with a high negative predictor value (99.4%).34,35 
However, considering ultrasound of the lower extremities 
in patients with high clinical suspicion for acute PE and a 
negative CT would appear prudent.36,37
Spiral CT scan requires a contrast bolus for vascular 
imaging. The most common contraindication to perform 
contrast enhanced spiral CT scanning is renal failure.37 
Uremia increases with advanced age and in hospitalized 
patients, essentially when patients are admitted for acute 
events which decompensate their renal function. Thirty 
five patients (36.8%) with suspicion of PE reported in 
these series (Table 2) had an increased plasmatic creatinin 
level which precluded investigation using spiral CT scan. 
  Fourteen patients had Alzheimer’s disease and 14 other 
patients presented with altered general and mental conditions 
preventing them to comply with the required conditions for 
completing a spiral CT scan examination. For these reasons, 
elderly patients, essentially when they are severely ill, need 
a less aggressive diagnostic procedure for confirming VTE. 
Table  1  Clinical  presentation  of  patients  with  confirmed  or 
excluded deep vein thrombosis of lower extremities
Clinical presentation Deep vein  
thrombosis 
(n = 33)




Dyspnea: 30 (93.9%) 48 (77.4%) 0.176







Lower extremity edema 11 (33.3%) 6 (9.6%) 0.004







Alteration of general status 5 (15.1%) 9 (14.5%) 0.999
Table 2 Risk factors in patients with confirmed or excluded deep 
vein thrombosis of lower extremities
Risk factor Deep vein  
thrombosis 
(n = 33)




Renal failure 14 (42.4%) 21 (33.8%) 0.411
History of VTE 9 (27.2%) 8 (12.9%) 0.082
Obesity 8 (24.2%) 7 (11.2%) 0.099
Hip fracture and surgery 5 (15.1%) 2 (3.2%) 0.047
Superficial venous  
insufficiency
3 (9%) 8 (12.9%) 0.742
immobilization 3 (9%) 6 (9.6%) 0.999
Heart failure 3 (9%) 12 (19.3%) 0.191
Recent surgery 3 (9%) 5 (8%) 0.999
Cancer 2 (6%) 4 (6.4%) 0.999
Respiratory failure 2 (6%) 4 (6.4%) 0.999
Lung infection 1 (3%) 6 (9.6%) 0.415
Sepsis 1 (3%) 1 (1.6%) 0.999
Hemiplegia 1 (3%) 0 0.347
Acute pancreatitis 1 (3%) 1 (1.6%) 0.999
Cardiac catheterization 1 (3%) 0 0.347
Chronic lung disease 0 12 (19.3%) 0.007
Coronary artery disease 0 12 (19.3%) 0.007
Quadriplegia 0 2 (3.2%) 0.541
Leg fracture 0 2 (3.2%) 0.541
intracranial bleeding 0 1 (1.6%) 0.999
Abbreviation: VTE, venous thromboembolism.
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Duplex scan of the veins of lower extremities, a cost-effective 
procedure14,38 essentially when unilateral symptoms are 
present,12 was an effective adjunct for PE diagnosis in this 
particular risk group. It could detect venous thrombosis in 
34.7% of this study’s hospitalized geriatric population with 
suspicion of PE, a rate exceeding two times that reported 
in the literature for population not selected according to 
hospitalization and advanced age (10%–18%).12–14 Thus, 
the combination of advanced age and hospitalization leads 
to an extremely high risk for VTE, significantly exceeding 
the separate effect of each of these single factors.
In these series, patients having chronic lung disease 
(chronic obstructive pulmonary disease, emphysema, asthma, 
and pulmonary fibrosis) and coronary artery disease (CAD) 
were less likely to have venous thrombosis (0% with lung 
disease compared with 19.3% with no lung disease, P = 0.007; 
and 9% with CAD compared with 19.3% with no CAD, 
P = 0.007). Although dyspnea was essentially related to 
the underlying cardiopulmonary condition in these patients, 
however, duplex scan was requested to detect any possible 
PE which could decompensate their cardiac or lung function. 
On the other hand, additional major PE in patients with very 
critical cardiopulmonary disease could lead to a lethal com-
plication before any possible exploration with duplex scan.
Hip surgery increased the incidence of venous thrombosis 
in the reported patients (15.1% in DVT compared with 3.2% 
in non-DVT; P = 0.047). Obesity seems to also increase 
venous thrombosis, although this factor did not reach statis-
tical significance (24.2% in DVT compared with 11.2% in 
non-DVT; P = 0.099).
The presence of lower extremity edema (33.3% in DVT 
compared with 9.6% in non-DVT; P = 0.004) was a pre-
dictor factor for positive ultrasound results. The role of a 
previous history of VTE in predicting positive ultrasound is 
highly suggestive but not statistically significant (27.2% in 
DVT compared with 12.9% in non-DVT; P = 0.082). These 
results confirm the findings reported by Girard and colleagues 
who demonstrated by a multivariate analysis of patients 
with symptomatic proved PE that age $70 years, the pres-
ence of symptoms and signs of DVT, and a history of VTE 
were independent risk factors for DVT.39 They emphasize 
the importance of duplex scan as a major contributor to the 
diagnostic strategy of PE in elderly hospitalized patients, 
essentially when symptoms and signs of DVT and/or a his-
tory of VTE are present.
This study demonstrates that lower extremity venous 
duplex scan is very useful in detecting venous thrombosis 
in geriatric inpatients with clinically suspected PE. It is a 
  noninvasive and reproductive exam which can be performed 
sometimes urgently on the floor or in the intensive care unit 
without the need to mobilize the patient. The role of this exam 
becomes essential when elderly patients have a very critical 
condition preventing their transfer to the radiology department, 
a renal failure, or altered mental or general status precluding 
the use of spiral CT scan, the standard of reference for the diag-
nosis of PE. In these specific conditions, duplex scan becomes 
an appropriate first-line test for the diagnosis of PE.
Conclusion
Lower extremity color flow venous duplex scan seems to be 
a useful adjunct or even an appropriate initial screening test 
for geriatric hospitalized patients with clinically suspected 
DVT. This test is particularly efficient in patients with a 
history of  VTE and/or with clinical presentation suggestive 
of DVT and is particularly useful in uremic patients and in 
patients with alteration of general and mental status who are 
not candidates for chest helical CT scan examination.
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